Search
for
Sort by
Research 211–240 of 1000+
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Evaluation of serum Level of Human Beta Defensin 1 patients With Alopecia Areata
- Microneedles along with conventional therapies: An in-depth observational review in alopecia areata treatment
- Alopecia Areata
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Frontal fibrosing alopecia: a disease that remains enigmatic
- Alopecia Areata after COVID-19 Vaccines
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Alopecia areata - probing the deforestation
- Bilaterally Symmetrical Alopecia With Reticulated Hyperpigmentation
- Insights into Alopecia Areata: A Systematic Review of Prevalence, Pathogenesis, and Psychological Consequences
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Supplementary Material for: Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Supplementary Material for: Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- 83 Transcriptomic meta-analysis and deconvolution approaches unveil cellular dynamics in scarring and non-scarring primary lymphocytic alopecias
- Potential etiological factors in frontal fibrosing alopecia
- A perspective on predictive markers of alopecia
- A study of the histopathological features of alopecias on transverse sections of scalp biopsies
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- Simultaneous Alopecia Areata in Identical Twins: First Case Reported in Saudi Arabia
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Alopecia Areata with Renal Dysgenesis
- New Treatment Options for Alopecia Areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Review on Alopecia: Disease and Characterstics, Clinical Evaluation, Psychological Impact & Available Treatment Options
- Alopecia areata during the convalescent phase of kawasaki disease
- Drug Armamentarium for alopecia areata
- Cutaneous Manifestations in Thyroid Disorders